Home Page News Statistics API Review Formulation Monthly Im&Ex report All Information
     
Keyword:
 E-mail:xuezhe@healthoo.com
 Tel.:86-10-68032463
　　Our services:
 China Im\Ex data service
 Service fees of Chinese Vision
 Our service items
Online information introduction
Monthly information
Conference on ...
Information Release...
Internationalization&nbs...
Welcome to Pro...
Healthoo.com Carbap...
APIs Innovation&nbs...
China Import Export Statistics Report In...
API Export Price by ...
Tylosin Bulk Drug Export&...
China Monthly Export Stat...
China Monthly Export Stat...
China Monthly Export Stat...
Your position:www.healthoo.com >> EN >> Industry
AstraZeneca adjusted business strategy in China2013-05-30
Meprobamate withdrawn from China''s market2013-05-28
Stalevo sold in China for Parkinson''s disease2013-05-28
Wanbang to expand insulin capacity2013-05-17
ScinoPharm and Coland to develop generic oncological drugs in China2013-05-14
TCM meeting closes in Germany2013-05-14
Amgen and Zhejiang Beta to commercialise Vectibix in China2013-05-13
China to issue international business standards of plant extracts2013-05-13
China plans crackdown on antiobiotics overuse2013-05-10
China''s biopharmaceutical industry booms2013-05-09
Takeda and Sanofi to develop diabetes drug Alogliptin in China2013-04-28
BMS to launch new diabetes drugs in China2013-04-26
Drug companies'' sales value rises 18% in 20122013-04-25
Nearly 120,000 new cases of TB in China ever year2013-04-25
Guangdong Kelun soon into production2013-04-19
New discharge standard of Citric Acid industry issued2013-04-18
Xinlitai build formulation project in Linyi2013-04-18
Tianma''s Meglumine passed cGMP2013-04-15
China approved peramivir for H7N9 bird flu2013-04-11
Gleevec and Tasigna into medical insurance of Jiangsu2013-03-28
Output value of pharmaceutical industry up 22% in first 2 months2013-03-27
Eli Lilly sets up innovation center in Dalian2013-03-21
Vitamin D3 first time exported from Jiaxing2013-03-21
National Essential Drugs List (2012 edition) issued2013-03-18
Production of Buflomedil is stopped in China2013-03-18
China to increase funding for medical reform2013-03-15
EV71 vaccine phase III trial got positive result2013-03-15
Fosun buys new business abroad2013-03-06
NCPC''s sales revenue reaches 16 bln Yuan in 20122013-03-04
China to encourage innovative drug development2013-02-27
Vitamin B1 and B6 export of Jingdezhen up 31%2013-02-20
Exp. and imp. value of pharmaceuticals up 10% in 20122013-02-19
共1471个 页次:13/46页 32个/页 首页 上一页 下一页 尾页 转到：
Our Advantages of Reports
①All reports written by ourselves
②All data having original sources
③Information is the latest
④Continuous historical data
⑤Objective analysis and remark
Purchase Flow of Reports
①Confirm purchase (If necessary sign the contract)
②Transfer payment to company's bank account
③After accepting payment we email the report to clients (PDF format)
④Send the invoice
Bank account
①Beneficiary's Name:Beijing orientbit technology ltd
②Beneficiary's Account No.:110060239018002127366
③Name of bank:Bank of Communications Beijing Branch，Fuwai Sub-Branch
④Address of bank:NO7，FUWAISTREET，XICHENG DISTRICT，BEIJING，CHINA SWIFT CODE：COMMCNSHBJG
Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463